# Outset Medical, Inc. (OM) · Edgar & Edgarette company card

> Outset Medical (OM) grew revenue 5.1% in FY2025 to $119 million, operating margin -55.8% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 48.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1484612 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/OM) · [JSON](https://www.pops4.com/boards/company/OM.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $119M |
| Revenue growth, 1 year | 5.1% |
| Revenue growth per year | 3.9% |
| Operating margin | -55.8% (prior year -99.7%) |
| Net margin | -68.3% |
| Operating cash flow | −$46M |
| Capital spending | $798,000 |
| Free cash flow | −$47M |
| Cash | $35M |
| Long-term debt | $96M |
| Total assets | $264M |
| Total equity | $127M |
| Equity ÷ assets | 48.0% |
| Return on equity | -64.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -9.87 (distress zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -3.2 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -55.8% in FY2025
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $119.5M (FY2025), total debt $96.2M. Experience: revenue up 5.1% on the year, up 3.9% a year over 4 years; operating margin -55.8%, up from -99.7%. Soundness: equity 48.0% of assets, return on equity -64.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $100.6M and $145.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $91.6M to $160.0M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, electromedical & electrotherapeutic apparatus): operating margin -55.8% against a 7.5% median; growth 5.1% against 8.3%.

Range logged 2026-09-24, receipt 89d12cccc2a238de, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-08-28 ([filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526374323/0001193125-26-374323-index.htm))

## Recent filings

- 10-Q · filed 2026-11-04 · [filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526447683/0001193125-26-447683-index.htm)
- 8-K · filed 2026-11-04 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526447293/0001193125-26-447293-index.htm)
- 8-K · filed 2026-08-28 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526374323/0001193125-26-374323-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526338432/0001193125-26-338432-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/0001193125-26-337953-index.htm)
- 8-K · filed 2026-06-17 · 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1484612/000119312526274135/0001193125-26-274135-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001484612.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1484612

## Cite

POPS4, Edgar & Edgarette: Outset Medical, Inc. (OM) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/OM. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.